Key points are not available for this paper at this time.
No discernable differences in protection against symptomatic BA.1 and BA.2 infection were seen with previous infection, vaccination, and hybrid immunity. Vaccination enhanced protection among persons who had had a previous infection. Hybrid immunity resulting from previous infection and recent booster vaccination conferred the strongest protection. (Funded by Weill Cornell Medicine-Qatar and others.).
Altarawneh et al. (Wed,) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: